| Date | Panel | Item | Activity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BabyScreen+ newborn screening v0.2015 | TNFRSF13C | Zornitza Stark Marked gene: TNFRSF13C as ready | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BabyScreen+ newborn screening v0.2015 | TNFRSF13C | Zornitza Stark Gene: tnfrsf13c has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BabyScreen+ newborn screening v0.2015 | TNFRSF13C | Zornitza Stark Classified gene: TNFRSF13C as Red List (low evidence) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BabyScreen+ newborn screening v0.2015 | TNFRSF13C | Zornitza Stark Gene: tnfrsf13c has been classified as Red List (Low Evidence). | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| BabyScreen+ newborn screening v0.2010 | TNFRSF13C |
Lilian Downie gene: TNFRSF13C was added gene: TNFRSF13C was added to Baby Screen+ newborn screening. Sources: Expert list Mode of inheritance for gene: TNFRSF13C was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: TNFRSF13C were set to PMID: 19666484, PMID: 27250108, PMID: 18025937 Phenotypes for gene: TNFRSF13C were set to Immunodeficiency, common variable, 4 MIM#613494 Review for gene: TNFRSF13C was set to RED Added comment: Amber in our mendeliome Later childhood or adult onset. BAFFR deficiency in humans is characterized by very few circulating B cells, very low IgM and IgG serum concentrations but normal or high IgA levels. Sources: Expert list |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||